Search clinical trials for: Minoxidil Tablets

Total 6696 results

Xi'an Xintong Pharmaceutical Research Co.,Ltd.

Unknown

A Study to Investigate the Safety, Tolerability, Pharmacokinetics of Single and Multiple Doses of Hepenofovir Fumarate Tablets in Healthy Volunteers.

Chronic Hepatitis b
Haisco Pharmaceutical Group Co., Ltd.

Recruiting

To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in China

Diabetic Peripheral Neuropathic Pain

China
Anji Pharma
Covance

Completed

A Proof of Concept Study of Pradigastat in Patients With Functional Constipation

Functional Constipation

China, United States
Centre Hospitalier Universitaire Vaudois
University College, London; Great Ormond Street Hospital for Children NHS Foundation...

Not yet recruiting

Repurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose Rationale

Heart Failure

Switzerland, United Kingdom
Pharma Plant
Novagenix Bioanalytical Drug R&D Center

Unknown

Bioequivalence Study of Favipiravir 200 mg Film Tablet (Pharma Plant, Turkey) Under Fasting Conditions

Bioequivalence

Turkey
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors

Advanced Cancers

China
Suzhou Genhouse Bio Co., Ltd.
Zhejiang Cancer Hospital; Henan Cancer Hospital; Hubei Cancer Hospital; The First...

Recruiting

A Phase Ia/Ib Study of GH2616 Tablet in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

China
FindCure Biosciences (ZhongShan) Co., Ltd.

Recruiting

A Study of Axl Inhibitor FC084CSA in Patients With Advanced Malignant Solid Tumors

Advanced Malignant Solid Tumors

China
GenEros Biopharma Hangzhou Ltd

Recruiting

Study of GEC255 in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation

Advanced Solid Tumors

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Study to Evaluate Orelabrutinib Tablets in Subjects With Hepatic Impairment and Healthy Subject

Hepatic Impairment

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A First-in-human Study of HRS2398 Tablets in Subjects With Advanced Malignant Tumors

Advanced Malignant Tumor

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Study of TQB3820 in Patients With Hematological Malignancies

Hematological Malignancies

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Active, not recruiting

TQ05105 Tablet for Myelofibrosis Treatment in Ruxolitinib-Resistant or Intolerant Patients

Myelofibrosis

China
Shanghai Pharmaceuticals Holding Co., Ltd

Completed

A Clinical Study of SPH6516 Tablets in the Treatment of Advanced Solid Tumors.

Advanced Solid Tumor

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Withdrawn

A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer

Advanced Malignant Neoplasm

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

To Evaluate the Effect of Food on the Pharmacokinetics of TQ05105 Tablets in Healthy Adult Subjects

Myelofibrosis

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Active, not recruiting

A Clinical Study of TQB3823 in Patients With Advanced Malignant Tumor

Advanced Solid Tumor

China
AstraZeneca

Completed

A Bioavailability Study Comparing 3 Different AZD1981 Tablets

Healthy

Sweden
Mundipharma Research GmbH & Co KG

Completed

OXN PR Compared to OxyPR to Demonstrate Non-inferiority in Pain & Locomotor Function & Improvement in Symptoms of Constipation in OA Subjects

Chronic Osteoarthritis

Spain, Belgium, Finland, Czechia, Germany, Hungary
Vaxart

Completed

A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine

COVID-19

United States
Maasstad Hospital
Daiichi Sankyo, Inc.; MicroPort Orthopedics Inc.; Research Maatschap Cardiologen...

Completed

CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI (CompareCrush)

Cardiovascular Diseases

Netherlands
Chengdu Baiyu Pharmaceutical Co., Ltd.

Recruiting

A Phase l Study of By101921, an Oral PARP7 Inhibitor, in Patients With Advanced Solid Tumors

Solid Tumor, Adult

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

A Clinical Trial of TQB3117 Tablets in Patients With Advanced Malignant Cancer

Advanced Malignant Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease

Chronic Graft Versus Host Disease

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer

Advanced Breast Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects

Hematologic Malignancy

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer Subjects

Castration-Resistant Prostate Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Study of TQB3824 in Subjects With Advanced Cancer

Advanced Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors

Advanced Malignant Tumor

China
Ningbo Newbay Technology Development Co., Ltd

Recruiting

A Study of NB003 in Patients With Advanced Malignancies

Advanced Solid Tumor

United States, Spain, China, Korea, Republic of, France, United Kingdom
Shanghai Pharmaceuticals Holding Co., Ltd

Completed

Phase I Clinical Study of SPH4336 Tablets in the Treatment of Advanced Solid Tumors

Advanced Solid Tumors

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Study to Evaluate the Effect of Different Meal Types on the Pharmacokinetics of DBPR108 in Healthy Subjects

Healthy Subjects

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of DBPR108 Tablets in Type 2 Diabetes Mellitus Patients

Type 2 Diabetes Mellitus

China
University of Alabama at Birmingham

Withdrawn

Mechanisms of Refractory Hypertension (High and Low Salt Diet)

Hypertension
Medical University of South Carolina
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills (TABLETS)

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin Dependent

United States
GlaxoSmithKline

Completed

Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers

Healthy Subjects | Dyslipidaemias

United States
Neuroscience Trials Australia
The Florey Institute of Neuroscience and Mental Health

Active, not recruiting

Deferiprone to Delay Dementia (The 3D Study)

Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Mild Alzheimer's Disease

Australia
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes

Type 2 Diabetes

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer

Advanced Malignant Neoplasm

China
Hua Medicine Limited
Shanghai Branch, KunTuo Medical Research and Development (Beijing) Co., Ltd.

Recruiting

A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes

Type2diabetes

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Study of TQB3454 Tablets in Patients With Blood Tumors

Acute Myeloid Leukemia | Myelodysplastic Syndromes

China
Convalife (Shanghai) Co., Ltd.

Not yet recruiting

CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency

Advanced Solid Tumors

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects

Biliary Carcinoma

China
Suzhou Junjing BioSciences Co., Ltd.
Sponsor GmbH

Recruiting

A Phase I/II Study of WJ13404 Monotherapy in Patients With Advanced or Mentastatic Non-Small Cell Lung Cancer

Locally Advanced or Metastatic NSCLC

China
Shanghai Pharmaceuticals Holding Co., Ltd

Recruiting

SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors

HER2-positive Advanced Solid Tumors

China
Haihe Biopharma Co., Ltd.

Recruiting

Evaluate the Safety and Clinical Activity of HH2853

Advanced Solid Tumor | Epithelioid Sarcoma | Peripheral T Cell Lymphoma | FL Lymphoma

China, United States
Novartis Pharmaceuticals

Active, not recruiting

Special Drug Use-results Surveillance of Tabrecta Tablets

Non-small Cell Lung Cancer

Japan
Jiangsu HengRui Medicine Co., Ltd.

Completed

Identify Effective Doses of SHR7280 Tablets in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART)

Female Subjects Undergoing COH in ART to Prevent Early Ovulation

China
Evopoint Biosciences Inc.

Completed

Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of XNW7201 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

Australia
A. Vogel AG

Completed

Study to Assess Safety and Efficacy of Nephrosolid Tbs to Stimulate Urinary Output in Non-patient Volunteers

Urine Specimen Collection

Switzerland

Search clinical trials for: Minoxidil Tablets

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations